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Human pluripotent stem cells can be differentiated into midbrain dopaminergic (mDA)
neurons by directing cells through a floor plate progenitor stage. The developmental
identity of mDA neurons produced using floor plate protocols is similar to substantia
nigra neurons, and this has improved the ability to model Parkinson’s disease (PD) in
a dish. Combined with the unlimited growth potential of pluripotent stem cells, mDA
neural progenitor cell production can provide a scalable source of human dopaminergic
(DA) neurons for diverse applications. However, due to the complexity and length of the
protocols and inherent differences between cell lines, considerable variability of the final
population of neurons is often observed. One solution to this problem is to cryopreserve
committed mDA neural progenitor cells in a ready-to-use format. Creating a bank of
cryopreserved mDA neural progenitor cells poised for neuronal differentiation could
significantly improve reproducibility and facilitate collaborations. Here we have compared
six (6) different commercial cryopreservation media and different freezing conditions for
mDA neural progenitor cells differentiated from human embryonic stem cell (hESC)
lines. Significant differences in cell recovery were observed at 24 h post-thawing,
but no differences were observed immediately upon thawing. The presence of ROCK
inhibitors improved cell recovery at 24 h for all cryopreservation media tested. A faster
cooling rate of 1–2◦C/min was significantly better than 0.5◦C/min for all conditions
tested, while rapid thawing at 37◦C was not always superior to slow thawing at 4◦C.
Importantly, cryopreservation of mDA neural progenitor cells did not alter their potential
to resume differentiation into mDA neurons. Banks of cryopreserved committed mDA
neural progenitor cells provide a method to generate human DA neurons with reduced
batch-to-batch variability, and establish a mechanism to share lineage-primed cells for
collaborative research.
Keywords: human embryonic stem cells, dopaminergic differentiation, midbrain dopaminergic neurons,
cryopreservation, Parkinson’s disease
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INTRODUCTION
Parkinson’s disease (PD) is a common neurodegenerative
condition characterized by progressive and selective neuronal cell
loss. Although the subtypes of neurons that become dysfunctional
and die in PD are diverse, the dopaminergic (DA) neurons of
the substantia nigra are particularly affected in this condition.
The embryological origin of nigral DA neurons is a population
of radial glial-like cells in the floor plate of the mesencephalon
(Ono et al., 2007; Bonilla et al., 2008). Significant progress has
been made in the last 10 years to produce floor plate cells and
authentic midbrain DA (mDA) neurons from human embryonic
stem cells (hESCs) and induced pluripotent stem cells (iPSCs)
(Fasano et al., 2010; Kriks et al., 2011; Kirkeby et al., 2012; Xi
et al., 2012). Single-cell RNAseq of hESC/iPSC-derived mDA
neurons generated by the floor plate protocol showed significant
overlap with multiple human fetal mDA cell types (La Manno
et al., 2016). The functionality of mDA neurons differentiated
from hESCs and iPSCs has been extensively investigated in in vivo
pre-clinical animal models of PD (Kriks et al., 2011; Kirkeby
et al., 2012; Kikuchi et al., 2017). hESC-derived mDA neural
progenitor cells, upon transplantation, could rescue the DA
deficit in the rat 6-hydroxydopamine (6-OHDA) lesion model
of PD and were demonstrated to be functionally equivalent
to human fetal ventral midbrain tissue (Grealish et al., 2014).
Furthermore, human iPSC-derived mDA neural progenitor cells,
FACS-sorted for the floor plate marker CORIN, could rescue a
macaque model of PD established by 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) lesion (Kikuchi et al., 2017). The
improved mDA differentiation protocols have also enhanced the
ability to model aspects of PD in a dish, including recapitulating
neuronal synucleinopathy (Chen et al., 2019), and investigation
of DA electrophysiology (Chen et al., 2020).
Differentiation of hESCs/iPSCs into mDA neurons is a
complex and multi-stage process, and it is known that different
iPSC lines from the same patient can have significantly
different propensities to produce mDA neurons (Devine et al.,
2011). Furthermore, the positional identity of floor plate cells
produced from hESCs/iPSCs is highly sensitive to small changes
in WNT signaling (Kirkeby et al., 2012). A cryopreserved
mDA neural progenitor cell bank could provide a quality-
controlled population of cells from which mDA neuronal
differentiation and maturation can be conducted. This will reduce
variability across experiments, and facilitate collaborations across
multiple laboratories.
Cryopreservation of primary rat fetal mesencephalic tissue
resulted in a greater than 50% loss of viability compared to
non-frozen cells, but the surviving neurons, when grafted into
the rat 6-OHDA lesion model, were able to ameliorate the
amphetamine-induced rotation phenotype (Sauer et al., 1992).
However, attempts to cryopreserve human fetal mesencephalic
tissue prior to functional assessment in the 6-OHDA lesion
model were less successful with more than 90% loss of
viable mDA cells compared to non-frozen controls, and no
significant rescue of amphetamine-induced rotations (Frodl
et al., 1994). More recently, successful cryopreservation of
hESC/iPSC-derived mDA cells using a floor plate protocol
has been reported (Niclis et al., 2017; Leitner et al., 2019).
Furthermore, commercial cryopreserved human iPSC-derived
mDA cells (iCell DopaNeurons) have been directly transplanted
into rat and non-human primate lesion models of PD (Wakeman
et al., 2017). Thawed mDA neural progenitor cells could
rescue amphetamine-induced rotations after transplantation into
the rat 6-OHDA lesion model, and survival and maturation
into mDA neurons was observed in the MPTP-lesion monkey
model (Wakeman et al., 2017). However, optimization of the
cryopreservation process has not been reported nor has there
been a systematic investigation to evaluate cryopreservation
conditions for mDA neural progenitor cells. Here we investigate
different cryopreservation conditions for human mDA neural
progenitor cells, present the first report comparing multiple
commercial cryopreservation media, and propose guidelines for
best practices to optimize cryopreservation of human ESC/iPSC-
derived cell products.
MATERIALS AND METHODS
Human Embryonic Stem Cell Culture
Approval for the use of MasterShef7 (MShef7) and RC17 hESCs
was granted by the MRC Steering Committee for the UK Stem
Cell Bank and for the Use of Stem Cell Lines (ref. SCSC13-
18 for MShef7 and ref. SCSC13-19 for RC17). RC17 hESC line,
kindly provided by Roslin Cells Limited, was derived under
Good Manufacturing Production (GMP) conditions (De Sousa
et al., 2016). MShef7 hESC line, kindly provided by Prof Harry
Moore, was derived in GMP conditions at the University of
Sheffield. RC17 and MShef7 lines have normal female and
male karyotypes, respectively, and both carry a single naturally-
occurring large copy number variation (>100 kb) that was
most likely present in the donated blastocyst (Canham et al.,
2015). hESCs were maintained in StemMACSTM iPS-Brew XF
(iPS-B, Miltenyi Biotec) on Laminin-521-coated plates (L521,
5 µg/ml, Biolamina). Once hESCs reached 70–90% confluency,
they were passaged as clumps using EDTA (0.5 mM, Thermo
Fisher Scientific).
Midbrain Dopaminergic Differentiation
Self-renewing hESCs were lifted with EDTA (0.5 mM),
counted, and plated for differentiation at 40,000 cells/cm2
on Laminin-111-coated plates (L111, 5 µg/ml, Biolamina) in
50% NeurobasalTM medium (Thermo Fisher Scientific), 50%
DMEM/F12 (Thermo Fisher Scientific), B27 (1:50, Thermo
Fisher Scientific), N2 (1:100, Thermo Fisher Scientific),
L-glutamine (2 mM, Thermo Fisher Scientific), Sonic hedgehog
(SHH-C24II, 600 ng/ml, R&D), CHIR99021 (0.9 or 1 µM,
Miltenyi Biotec), SB431542 (10 µM, Tocris), LDN193189
(100 nM, Stemgent), and Y27632 (10 µM, Tocris). The culture
medium was exchanged on day 2 with the above medium
without Y27632. On day 4 and day 7, cells were fed with medium
consisting of 50% Neurobasal, 50% DMEM/F12, B27 (1:100),
N2 (1:200), L-glutamine (2 mM), SHH-C24II (600 ng/ml),
CHIR99021 (0.9 or 1 µM), SB431542 (10 µM), and LDN193189
(100 nM). On day 9, cells were fed with the above medium
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supplemented with FGF8b (100 ng/ml, R&D) and heparin
(1 µg/ml, Sigma). On day 11, cells were lifted using Accutase
(Sigma) and re-plated at 800,000 cells/cm2 on L111-coated
plates in Neurobasal medium supplemented with B27 (1:50),
L-glutamine (2 mM), BDNF (20 ng/ml, Peprotech), GDNF
(10 ng/ml, Peprotech), ascorbic acid (0.2 mM, Sigma), FGF8b
(100 ng/ml), heparin (1 µg/ml), and Y27632 (10 µM). Cells were
fed on day 14 with day 11 medium without Y27632. On day
16, cells were lifted with Accutase and either (i) cryopreserved
or (ii) re-plated at 800,000 cells/cm2 on L111-coated plates
in Neurobasal medium with B27 (1:50), L-glutamine (2 mM),
BDNF (20 ng/ml), GDNF (10 ng/ml), ascorbic acid (0.2 mM),
dibutyryl cyclic AMP (db-cAMP, 0.5 mM, Sigma), DAPT (1 µM,
Tocris), and Y27632 (10 µM). From day 18 onward, medium was
exchanged every 2–3 days. A detailed version of this protocol is
available at: dx.doi.org/10.17504/protocols.io.bddpi25n.
Cryopreservation
At day 16 of differentiation, cells were lifted using Accutase
and counted using TC20TM Automated Cell counter (BioRad).
Cells were centrifuged (300 g, 3 min) and resuspended in the
appropriate freezing medium (Table 1) at 1.02 × 107 cells/ml
and 100 µl of cell suspension was added to each 0.5-ml cryovial
(FluidX). Cells were frozen in a VIA FreezeTM Duo controlled-
rate freezer (Cytiva, Cambridge, United Kingdom) using the
following protocol: 4◦C hold for 10 min and then temperature
was reduced at 0.5, 1, or 2◦C/min until −80◦C was reached.
Cryovials were transported on dry ice and transferred to vapor
phase liquid nitrogen (∼−170◦C) for long term storage.
Thawing and Cell Counting
Cells were thawed by exposing the vial to 37◦C water for
1–2 min (rapid thawing) or by placing the vial in air
at 4◦C for approximately 10 min (slow thawing). The cell
suspension was removed from the cryovial and placed onto
1 ml NeurobasalTM medium with B27 (1:50) and L-glutamine
(2 mM) and centrifuged (300 g, 3 min). The supernatant was
removed and the cell pellet was resuspended in 300 µl of day






STEM-CELLBANKER R© SCB 10% DMSO Amsbio
Synth-a-FreezeTM
Medium
SYF 10% DMSO Thermo Fisher
PSC Cryopreservation
Medium
PSC 10% DMSO Thermo Fisher
CryoStor R© CS10
Freeze Medium
CS10 10% DMSO BioLife Solutions
CryoStor R© CS5 Freeze
Medium




CV DMSO-free MP Biomedicals
Hibernation medium
HypoThermosol R© Hypo DMSO-free BioLife Solutions
16 differentiation medium supplemented with either Y27632
(10 µM) or RevitaCellTM (1X, Thermo Fisher Scientific). An
aliquot of cells was taken for cell counting (0 h cell count)
prior to plating in L111-coated 48-well plates (Corning); 24 h
later, the conditioned medium was collected and combined with
a DPBS wash of the cells to collect all the floating cells. This
was centrifuged (300 g, 3 min) and cells were resuspended in a
small volume (20–120 µl) of Neurobasal medium and counted in
the presence of Trypan Blue using the TC20TM Automated Cell
counter (Bio-Rad) (24 h floating cell count). The adherent cells
were lifted with Accutase and similarly counted (24 h attached
cell count).
Immunofluorescence Staining and Image
Quantification
Cells were fixed with 4% formaldehyde for 20 min and washed
three times in PBS. Blocking buffer (0.1% Triton X-100, 2% goat
serum or donkey serum in PBS) was added to fixed cells for
30 min. Primary antibodies TH (1:1000, rabbit, Millipore), β-III
tubulin (1:1000, mouse IgG2a, R&D), LMX1A (1:2000, rabbit,
Millipore), FOXA2 (1:100, goat, Santa Cruz), EN1 (1:50, rabbit,
GeneTex), and CORIN (1:1000, rat, R&D) were incubated with
fixed cells overnight at 4◦C and then washed three times in
PBS with 0.1% Triton X-100. Secondary antibodies (Thermo
Fisher Scientific) in blocking buffer were incubated with cells
for 2 h in the dark at room temperature. They were washed
three times in PBS with Triton X-100 and incubated with DAPI
(10 µg/ml, Thermo Fisher Scientific) before imaging on an
Olympus IX51 inverted microscope. Quantification of TH and
β-III tubulin immunostaining was performed with Fiji software
(Schindelin et al., 2012). Briefly, RGB images were converted to 8-
bit grayscale, and then manually thresholded during conversion
to binary images. Efficiency of DA neuronal differentiation was
estimated by calculating the ratio of total TH to total β-III tubulin
immunostaining for each image.
FACS
Human embryonic stem cells and cells at day 16 of differentiation
were lifted with Accutase, centrifuged (2150 g, 1.5 min), and
resuspended in FACS Buffer (PBS + 2% FBS) with CORIN
antibody (1:200, rat, R&D), and incubated for 15 min on ice. A rat
IgG isotype antibody was used for the control FACS. Cells were
then centrifuged and washed in FACS Buffer and incubated on
ice (15 min) with secondary antibody donkey anti-rat IgG Alexa
Fluor-488 (Thermo Fisher Scientific). Cells were centrifuged and
washed in FACS Buffer and flow cytometry data were collected
using the FACS Calibur (BD Biosciences) and post-acquisition
analysis was performed using FlowJo software.
RT-qPCR
RNA extraction was performed using the MasterPureTM
Complete DNA and RNA Purification Kit (Epicenter, MC85200),
according to manufacturer’s instructions. RNA concentration
was quantified using a NanoDrop spectrophotometer. Total
RNA (1 µg in 10 µl) was used for cDNA synthesis. The
samples were incubated with 1 µl dNTP mix (10 mM, Thermo
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Fisher Scientific) and 1 µl Random Primer Mix (60 µM,
NEB) at 65◦C for 5 min and then chilled on ice. After
a brief centrifugation, 4 µl 5x First-strand buffer (Thermo
Fisher Scientific), 2 µl DTT (0.1 M, Thermo Fisher Scientific),
and 1 µl RNaseOUT (40 units/µl, Thermo Fisher Scientific)
were added. The contents were incubated at 37◦C for 2 min
before 1 µl M-MLV reverse transcriptase (200 units/µl, Thermo
Fisher Scientific) was added. This was incubated at room
temperature for 10 min and then 37◦C for 1 h. The reaction
was inactivated at 90◦C for 10 min. qPCR was performed
using the Roche LightCycler R© 480 System with the Universal
Probe Library (UPL) (Roche). The Roche UPL Assay design
center was used to design forward (F) and reverse (R) intron-
spanning primers with a specific UPL probe for each gene (TBP
F-gaacatcatggatcagaacaaca R-atagggattccgggagtcat, Probe 87;
LMX1A F-tggaggagaacttccaaagc R-cagacagacttggggctcac, Probe
3; FOXA2 F-gggtgattgctggtcgttt R-atactggaagccgagtgcat, Probe
5; EN1 F-gcacacgttattcggatcg R-gcttgtcctccttctcgttc, Probe 88;
NURR1 F-atttcctcgaaaacgcctgt R-catactgcgcctgaacacaa, Probe 41;
PITX3 F-tgtcagacgctggcactc R-ccgaggccttttctgagtc, Probe 24;
TH F-gattccccgtgtggagtaca R-aagcaaaggcctccaggt, Probe 12).
Reactions (10 µl) containing primers, UPL Probe, LightCycler R©
480 Probes Master mix (Roche), and PCR water were performed
in 384-well plates as described in the manufacturer’s instructions.
The results were normalized to transcript levels of TATA-binding
protein (TBP).
RESULTS
Two clinical-grade hESC lines, MasterShef7 (MShef7) and RC17,
were chosen for this study since they efficiently differentiated
into mDA neural progenitor cells and into mDA neurons using a
modified 2D floor plate protocol (Kriks et al., 2011; Kirkeby et al.,
2017). Briefly, hESCs were plated onto a matrix of Laminin-111 in
the presence of dual-Smad inhibition (SB431542+ LDN193189),
0.9–1 µM GSK3β inhibitor (CHIR99021), and 600 ng/ml Sonic
hedgehog (SHH-C24II). FGF8b and heparin were added at
day 9 of differentiation, and brain derived neurotrophic factor
(BDNF) and glial cell derived neurotrophic factor (GDNF) were
added at day 11 (Figure 1A). The differentiating mDA neural
progenitor cells can be conveniently cryopreserved at day 11
or day 16 of differentiation, since these are time-points when
the cells are lifted and re-plated in the protocol. However, for
all experiments in this study, cells were frozen at day 16 since
cells at this stage of maturity can be transplanted into pre-
clinical rat models of Parkinson’s (Kirkeby et al., 2012), and no
further re-plating steps are required to produce mature mDA
neurons. In order to examine the in vitro differentiation potential
of the cryopreserved cells, the mDA neural progenitor cells
are thawed onto Laminin-111 in the presence of neurotrophic
and neuronal maturation factors to resume differentiation into
mDA neurons up to day 45 (Figure 1A). At the point of
freezing (day 16), the vast majority of cells expressed the mDA
markers, LMX1A, FOXA2, and Engrailed1 (EN1) as determined
by immunocytochemistry (Figures 1B,C), and transcripts for
these three transcription factors increased significantly during
the differentiation process (Figure 1D). Flow cytometry for
CORIN, a ventral floor plate marker, demonstrated that MShef7
and RC17 hESCs routinely produced ∼90% CORIN-positive
cells by day 16 of differentiation (Figures 1E,F). Furthermore,
immunocytochemistry at day 16 revealed that LMX1A-positive
cells exhibited cytoplasmic or membrane immunostaining for
CORIN (Figure 1G).
Human embryonic stem cell-derived mDA neural progenitor
cells were cryopreserved at a density of ∼1 × 107 cells/ml
in a total volume of 100 µl in six (6) different clinical-grade
cryopreservation media that are commercially available (Table 1).
This relatively small volume was used to facilitate uniform
thawing and the high cell density was published to improve cell
viability when compared to cells frozen at ∼1 × 106 cells/ml
(Terry et al., 2010). The media investigated included (i) STEM-
CELLBANKER R© (SCB), (ii) Synth-a-FreezeTM Medium (SYF),
(iii) PSC Cryopreservation Medium (PSC), (iv) CryoStor R©
CS10 Freeze Medium, (v) CryoStor R© CS5 Freeze Medium, and
(vi) Cellvation Cryopreservation Medium (CV). CS5 contained
5% DMSO (v/v), while CV is a DMSO-free cryopreservation
medium. The other four cryopreservation media contained 10%
DMSO (v/v). HypoThermosol R©, a 4◦C DMSO-free hibernation
medium, was used as a negative control for these experiments.
Cooling rates were varied from 0.5 to 2◦C/min using a VIA
FreezeTM Duo controlled-rate freezer starting from 4◦C and
stopping at −80◦C before transferring vials to vapor phase
liquid nitrogen storage (Figure 2). The vapor phase of liquid
nitrogen (below−170◦C) was chosen since this is below the glass
transition temperature of cells in cryoprotectant (∼−120◦C),
and biological material is known to be highly stable at this
temperature with no changes in cell viability for over 1 year
(Silani et al., 1988; Massie et al., 2013; Meneghel et al., 2019).
The recovery of mDA neural progenitor cells was performed by
either thawing vials slowly in air at 4◦C or rapidly in a water-bath
set to 37◦C. Cell viability was assessed by Trypan blue exclusion
immediately upon thawing prior to plating in mDA neuronal
differentiation conditions, and again at 24 h post-thawing. The
latter cell viability test was performed since cryopreservation-
induced apoptosis is reported to occur in some cell types 12–
24 h after thawing (Baust et al., 2001). In order to gain a more
detailed account of the cell population, both floating cells and
attached cells were counted at 24 h post-thawing (Figure 2).
However, even this will not capture the fate of all cells, since some
cryopreserved cells will be mechanically destroyed during the
freezing and thawing process due to irreversible intracellular ice
crystal formation (Murray and Gibson, 2020). These destroyed
cells will be missing from the live/dead and attached/floating cell
counts. For this reason, we calculate both cell viability and cell
recovery, the latter defined as a percentage of cells initially frozen.
Rho-associated kinase (ROCK) inhibitors improved viability
of single hESCs upon passaging and after cryopreservation
(Watanabe et al., 2007), and they significantly improved
the recovery of cryopreserved hESC-derived cardiomyocytes
(Kim et al., 2011). Therefore, we first compared Y27632
(10 µM), a cell-permeable ROCK inhibitor, with the commercial
formulation, RevitaCellTM, which contains a ROCK inhibitor
and antioxidants. At 24 h post-thawing both RevitaCellTM and
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FIGURE 1 | Differentiation of human embryonic stem cells (hESCs) into midbrain dopaminergic (mDA) precursors for cryopreservation. (A) Schematic of the mDA
differentiation protocol. hESCs are plated as clumps on day 0 in the presence of dual SMAD inhibitors, SB431542 + LDN193189, Sonic hedgehog (SHH), and the
GSK3β inhibitor, CHIR99021. At day 9, the medium is switched to contain only FGF8b and the co-factor heparin, and cells are lifted and re-plated at day 11 when
the neurotrophic factors BDNF and GDNF are added. At day 16, the cells are lifted and counted for cryopreservation. Live/dead cell counts were performed
immediately upon thawing and at 24 h after thawing (day 17). mDA neuronal maturation was conducted in the presence of BDNF, GDNF, db-cAMP, ascorbic acid
(AA), and the Notch inhibitor DAPT, up to day 45. Co-immunostaining for midbrain floor plate markers, FOXA2 with LMX1A (B), and FOXA2 with EN1 (C), at day 16
revealed near homogenous expression at the point of cryopreservation. Scale bar, 120 µm. (D) RT-qPCR analysis of LMX1A, FOXA2, and EN1 expression relative to
TBP at Day 0, 11, and 16 of differentiation for three independent experiments (n = 3). (E) FACS analysis for CORIN expression at day 16 showed the majority of cells
expressed this ventral floor plate marker. The control FACS with rat isotype control antibody is shown in the inset. (F) Percentage CORIN-positive cells as determined
by FACS for undifferentiated day 0 MShef7 hESCs (n = 2) and RC17 hESCs (n = 2), and day 16 MShef7-derived (n = 8) and RC17-derived (n = 6) mDA neural
progenitor cells. (G) Co-immunostaining of day 16 MShef7-derived mDA neural progenitor cells for CORIN and LMX1A. Scale bar, 120 µm.
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FIGURE 2 | Cryopreservation experimental procedure. (A) At day 16 of mDA differentiation, cells were lifted, counted, and resuspended in a clinical-grade
cryopreservation medium prior to transferring to FluidX cryovials. (B) Cryovials were placed in the VIA Freeze controlled-rate freezer and cells were cryopreserved at
a constant rate of cooling between 0.5 and 2◦C/min to a final temperature of –80◦C. (C) Cryovials were transferred to the vapor phase of liquid nitrogen for long term
storage. (D) Cryopreserved cells were thawed at 4 or 37◦C. (E) A live/dead cell count was performed immediately after thawing (0 h count) prior to plating the cells.
(F) 24 h after plating cells (day 17 of differentiation) the non-adherent floating cells and the adherent attached cells were subjected to live/dead cell counts
(“24 h—Floating” count and “24 h—Attached” count, respectively).
Y27632 significantly increased the number of attached live mDA
neural progenitor cells (Figure 3A), and significantly reduced the
number of floating cells (Figure 3B). There were no significant
differences between RevitaCellTM and Y27632 by these measures.
Since RevitaCellTM is manufactured at clinical-grade for medical
devices (21 CFR Part 820 and ISO 13485), it was used for all
subsequent experiments.
We conducted a side-by-side comparison of six commercially-
available, clinical-grade cryopreservation media, and a DMSO-
free hibernation medium, HypoThermasol R© (Hypo) (Table 1).
Cell viability immediately upon thawing was not significantly
different for all cryopreservation media, nor was it significantly
different to the hibernation medium (Figure 3C). However,
at 24 h post-thawing, there were significant differences in cell
viability for the different cryopreservation media tested. Cells
frozen in the hibernation medium, Hypo, gave the lowest level
of cell viability, while PSC Cryopreservation Medium was the
only one that was not significantly different from freshly passaged
cells (Figure 3D). Cellvation, a DMSO-free cryopreservation
medium, was not significantly worse than the DMSO-containing
cryopreservation media, while Hypo was significantly worse
than PSC, CS10, CS5, and SCB cryopreservation media
(Supplementary Table S2). The number of floating cells at
24 h post-thawing was significantly higher for cells frozen in
SYF, CV, and Hypo media, but not for cells cryopreserved
in PSC, CS10, CS5, or SCB media (Figure 3E). When the
data are analyzed for cell recovery, defined as a percentage of
viable cells to the initial number of frozen cells, there were
no significance differences in cell recovery immediately upon
thawing for any of the media (Figure 3F), but at 24 h post-
thawing the DMSO-free media, CV and Hypo, had significantly
lower percentages of live recovered cells than the best-performing
medium, PSC (Figure 3G). While the performance of CV
and Hypo were not significantly different from each other
by this measure, Hypo was significantly poorer than all the
DMSO-containing cryopreservation media, while the DMSO-
free CV media was not statistically different from SCB and
SYF media, which contain 10% DMSO (v/v) (Supplementary
Table S2).
Since PSC was the best-performing cryopreservation medium
in the head-to-head comparison (Figure 3D), we attempted to
further improve cell recovery by investigating three different
cooling rates and two thawing conditions. We also included
CS5 and CV media, which contained 5% DMSO and 0%
DMSO, respectively, since the presence of DMSO could affect
downstream differentiation (Pal et al., 2012). For PSC media, 1
and 2◦C/min were significantly better than 0.5◦C/min at 24 h
post-thawing, while there were no significant differences for cells
frozen in CS5 medium (Figures 4A,B). For the DMSO-free CV
medium, the fastest freezing rate of 2◦C/min was significantly
better than the slowest rate of 0.5◦C/min (Figure 4C). Although
it is common practice to thaw cells rapidly in a warm water-
bath, we found that slow thawing in cool conditions (10 min
at 4◦C) was significantly better than fast thawing at 37◦C
for cells frozen in PSC media (Figure 4D). However, mDA
neural progenitor cryopreserved in CS5 or CV media did
not show significant differences between the slow and rapid
thawing conditions (Figures 4E,F). mDA neural progenitor cells
differentiated from another hESC line, RC17, also exhibited
excellent survival 24 h post-thawing after cryopreservation in
PSC medium (Figure 4G). In agreement with the MShef7 data,
slow thawing at 4◦C was equivalent, if not superior, to rapid
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FIGURE 3 | Assessment of cell viability after cryopreservation in the presence or absence of ROCK inhibitors, and using seven different clinical-grade media. (A,B)
Cell viability of mDA cells after cryopreservation in the absence of ROCK inhibitors or in the presence of RevitaCellTM or Y27632. (A) Live/dead attached cell
numbers at 24 h after thawing, and (B) total number of floating cells at 24 h (n = 2 experimental replicates). (C) Comparison of cell viability after cryopreservation in
PSC Cryopreservation Medium (PSC), CryoStor R© CS10 Freeze Media (CS10), CryoStor R© CS5 Freeze Media (CS5), STEM-CELLBANKER R© (SCB), Synth-a-Freeze
Medium (SYF), Cellvation Cryopreservation Medium (CV), and Hypothermosol R© (Hypo) immediately after thawing. At 24 h post-thawing live/dead cell counts of the
attached cells (D) and total floating cells (E) were determined (n = 3 experimental replicates), and compared to freshly passaged cells (n = 6 experimental replicates).
Live cells as a percentage of initial cell number frozen immediately upon thawing (F), and attached cells at 24 h post-thawing (G) (n = 3 experimental replicates). ns,
not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 one-way ANOVA with Tukey’s multiple comparisons test.
thawing at 37◦C for RC17-derived mDA neural progenitor cells
frozen in PSC medium (Figure 4G). Cells frozen in the 5% DMSO
medium, CS5, did not recover as well as cells cryopreserved
in PSC medium; however, there was a trend toward better
survival in the rapid 37◦C thawing condition for mDA neural
progenitor cells differentiated from both MShef7 and RC17 cell
lines (Figures 4E,H).
Next we directly compared the differentiation potential of
MShef7 and RC17-derived non-frozen cells to mDA neural
progenitor cells frozen at day 16 in the optimized condition:
PSC cryopreservation medium cooled at 1◦C/min and thawed
slowly at 4◦C. At 45 days of DA neuronal differentiation,
there were no gross differences in the production of neurons
for cells frozen at day 16 when compared to non-frozen cells
in terms of morphology or expression of the pan-neuronal
marker βIII-tubulin and the DA marker, tyrosine hydroxylase
(TH) (Figures 5A,B). Quantification of TH immunostaining
with respect to βIII-tubulin expression for both MShef7 and
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FIGURE 4 | Cell recovery at different cooling rates and thawing conditions. Percentage of live attached cells recovered 24 h after thawing for cells cryopreserved at
different cooling rates, 0.5, 1.0, and 2.0◦C per minute, in PSC (A), CS5 (B), or CV (C) cryopreservation media in three independent experiments (n = 3). *p < 0.05,
**p < 0.01, one-way ANOVA with Tukey’s multiple comparisons test. (D–F) Cell recovery at 24 h post-thawing for mDA cells frozen in PSC (n = 5), CS5 (n = 3), or CV
(n = 3) cryopreservation media and thawed at 4 or 37◦C in three to five independent experiments. *p < 0.05, unpaired t-test with Welch’s correction. (G,H) Cell
recovery of RC17-derived mDA cells at different thaw rates (37 versus 4◦C) in PSC and CS5 cryopreservation medium (n = 2 experimental replicates).
RC17 hESC-derived neurons at day 45 of differentiation did
not reveal any significant differences between non-frozen cells
and cells frozen at day 16 of the protocol (Figure 5C).
Gene expression analysis of TH, and mDA transcription
factor markers, NURR1 and PITX3, also did not reveal any
significant differences between frozen and non-frozen mDA
neural progenitor cells differentiated from both MShef7 and
RC17 hESC lines (Figure 5D).
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FIGURE 5 | Marker analysis of continuously differentiated mDA neurons versus neurons that were cryopreserved at day 16 as mDA neural progenitor cells.
Immunofluorescence staining for the pan-neuronal marker, βIII-tubulin (βIII), and dopaminergic marker, tyrosine hydroxylase (TH), at day 45 of differentiation of
MShef7 hESCs without freezing (A) or with freezing (B) at day 16. Zoomed-in areas designated by dashed lines. Scale bars, 220 µm. (C) Image quantification of TH
immunostaining as a fraction of βIII-tubulin immunostaining for non-frozen and frozen mDA neurons differentiated from MShef7 and RC17 hESC lines (n = 1
experimental replicate for each cell line, three to four images per condition). (D) RT-qPCR gene expression analysis of mDA markers TH, NURR1, and PITX3 at day
42 of differentiation from MShef7 and RC17 hESC lines (n = 3 experimental replicates).
DISCUSSION
Human pluripotent stem cells are unique because they can
produce cell types of all three germ layers in culture, maintain
high chromosomal stability, and are practically immortal
(Thomson et al., 1998; Takahashi et al., 2007). These properties
make hESCs and iPSCs ideal for modeling disease in a
dish, as well as providing an unlimited source of cells
for regenerative medicine applications (Cohen and Melton,
2011; Tabar and Studer, 2014). Numerous protocols exist to
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differentiate hESCs/iPSCs into a diverse range of cell types,
including many ectodermal and neuronal subtypes (Tchieu
et al., 2017). Recent advances in differentiation of ventral mDA
neurons have provided a significant opportunity to model PD
in a dish, and it has accelerated the route to cell replacement
therapies for this condition (Barker et al., 2017). Although
current differentiation protocols can produce high yields of
mDA neurons, cell line-to-cell line differences continue to
exist, as well as other sources of variation due in part to the
complexity of the protocol (Nolbrant et al., 2017). It is well
described that different hESC and iPSC lines have variable
potency of directed differentiation into neurons and other
cell types (Wu et al., 2007; Osafune et al., 2008; Hu et al.,
2010). One solution to this is to produce a quality-controlled
cryopreserved bank of mDA neural progenitor cells from which
all experiments are initiated. This is a similar concept to the
proposed CryoPause methodology where banks of hESCs or
iPSCs are cryopreserved at one passage in a ready-to-differentiate
format, without the need for expansion (Wong et al., 2017). Here
we propose that mDA neural progenitor cells, frozen in a ready-
to-use format, will significantly improve the reproducibility
of disease modeling, and could facilitate efforts toward cell
replacement therapy. A cryopreserved transplantation-ready
mDA cell product would provide a critical opportunity for quality
control measures, such as efficacy testing and safety assessments.
The feasibility of a “poised” partially differentiated cell product
was demonstrated when frozen iCell DopaNeurons were shown
to be capable of rescuing the 6-OHDA lesion rat model of PD
(Wakeman et al., 2017).
Since there is often significant cell loss associated with freezing
and thawing of cells, we took a systematic approach to examine
multiple aspects of the cryopreservation process in order to
maximize the yield of viable mDA neural progenitor cells. To this
end, we identified six commercially-available cryopreservation
media to test against each other (Table 1), and investigated
a clinical-grade 4◦C hibernation medium, HypoThermosol R©
(Hypo), which has been used to cryopreserve cells in the
literature (Baust et al., 2000). We investigated different cooling
rates with the VIA FreezeTM Duo controlled-rate freezer, and
compared rapid versus slow thawing of cells (Figure 2). We
focused our cryopreservation experiments on day 16 of the mDA
protocol, since this is the day that we lift the differentiating
cells for re-plating, and this is the optimal stage of maturity
for transplantation into the rat 6-OHDA lesion model of PD
(Kirkeby et al., 2012). We first investigated the addition of a
selective Rho-associated coiled-coil kinase (ROCK) inhibitor,
Y27632, and the supplement RevitacellTM that contains a ROCK
inhibitor, to the recovery medium. We found that both agents
significantly improved cell survival and cell recovery in the first
24 h after thawing (Figures 3A,B). These observations are in
agreement with published work demonstrating that inhibition of
ROCK in the first 12 h after passaging or thawing of cells prevents
apoptosis in a number of cell types including hESCs and neurons
(Watanabe et al., 2007; Lingor et al., 2008).
Surprisingly, there were no significant differences in cell
viability immediately after thawing cells for any of the
cryopreservation media, including the hibernation medium,
Hypo (Figure 3C). Differences only emerged when cell
viability and recovery were investigated at 24 h post-thawing
(Figure 3D). At this time-point, Hypo was the worst-performing
cryopreservation media, followed by SYF and CV, while the best-
performing media, PSC, was not significantly different to freshly
passaged cells (Figure 3D). The observations of cell viability at
0 and 24 h post-thawing are in agreement with data describing
cryopreservation-induced delayed onset of cell death (Baust et al.,
2000, 2001, 2009). Quantification of apoptosis in the first 48 h
after thawing MDCK cells identified the highest rates of apoptosis
to be between 12 and 24 h (Baust et al., 2001). This work and
our observations strongly indicate that measuring cell viability
and total cell recovery at 24 h post-thawing, not immediately
upon thawing, is essential to evaluate the quality and efficiency
of a cryopreservation process. Furthermore, an indirect, non-
invasive measure of the efficiency of a cryopreservation protocol
for adherent cells can be inferred from the number of floating
cells at 24 h post-thawing (Figure 3E). This identified Hypo,
CV, and SYF as significantly poorer than other cryopreservation
media for mDA neural progenitor cells. Although DMSO-free
CV medium was the worst-performing cryopreservation medium
tested, it was consistently better than Hypo by all measures at
24 h post-thawing. DMSO is a highly effective cryopreservation
agent, but other solutes, such as glycerol, can provide a measure
of cryoprotection (Lovelock and Bishop, 1959).
Varying the cooling rate resulted in significant differences in
24 h post-thaw cell recovery for PSC and CV cryopreservation
media, where faster cooling rates (1 and 2◦C/min) were generally
better than a slow cooling rate of 0.5◦C/min (Figures 4A,C).
Varying the cooling rate for cells frozen in CS5 media did not
result in any significant differences in cell viability (Figure 4B).
Slow cooling rates are known to avoid intracellular ice crystal
formation in part by allowing the cells sufficient time to lose
water (Mazur, 1963); however, excessively slow cooling may
result in DMSO toxicity. Optimal cooling rates are dependent
on cell type, but also cryoprotectant as we have seen here. Some
cryoprotectants containing extracellular solutes will enhance cell
dehydration, therefore allowing sufficient dehydration at more
rapid cooling rates. Other solutes may be more toxic, and
therefore cells will be more sensitive to slower cooling rates
where cells remain in the cryoprotectant longer before reaching a
cryopreserved state (Fuller, 2004).
We next investigated rapid versus slow thawing conditions.
Cryopreserved cells are typically thawed quickly in a 37◦C water-
bath, and slow thawing is usually considered undesirable, which
is supported by limited experimental data from the 1970s (Harris
and Griffiths, 1977; Akhtar et al., 1979). However, warming rates
for cryopreserved mammalian somatic cells were recently re-
visited, and no impact of thawing conditions could be identified
for cells cooled slowly at a rate of 1◦C/min (Baboo et al., 2019).
Rapid thawing was only beneficial for cells that were frozen
quickly at 10◦C/min or faster. Such rapid rates of cooling result in
only partial ice crystal formation, and rapid thawing could rescue
some damage due to re-crystallization on warming. If cells are
cryopreserved slowly in optimal conditions, then the warming
rate had little impact on viability as ice crystals fully develop
during the cooling process (Baboo et al., 2019). In agreement with
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these data, we did not observe a significant improvement in cell
viability or total cell recovery for cells thawing quickly in a 37◦C
water-bath compared to cells thawed slowly in air at 4◦C. In fact,
slow thawing at 4◦C for MShef7-derived mDA neural progenitor
cells was significantly better than rapid thawing (Figure 4D). An
additional reason why slow thawing might be beneficial could be
the non-uniform nature of thawing frozen liquids, which could be
exaggerated during rapid thawing. Ice does not melt uniformly
at the microscale, and it can melt in some places, and re-
freeze in other places, leading to pockets of ice re-crystallization
that can damage cells. Slow thawing could reduce these micro-
fluctuations. Recent studies with HepG2 cells suggested slow
thawing up to −10◦C, and then rapid thawing from −10 to 4◦C
is beneficial due to the reduction of such fluctuations (Kilbride
et al., 2017). Finally, rapid thawing may not be beneficial due
to the potential for increased toxicity of DMSO, especially if
temperatures approach 37◦C before wash-out (Morris et al.,
2016). Controlled-rate thawing to 4◦C, followed by immediate
dilution of cells in cold medium prior to centrifugation, could
minimize potential toxic effects of DMSO.
We next directly compared the neuronal differentiation
potential of MShef7 and RC17-derived cryopreserved mDA
neural progenitor cells to non-frozen cells up to 45 days of
differentiation. There were no gross morphological differences
nor quantitative differences in TH immunostaining between the
mDA neurons produced from frozen versus non-frozen cells
(Figures 5A–C). Furthermore, we did not observe any significant
differences in gene expression of DA markers, TH, NURR1, and
PITX3 for frozen versus non-frozen DA neurons differentiated
from RC17 and MShef7 hESCs (Figure 5D).
This study provides the first systematic investigation of
cryopreservation conditions for human mDA neural progenitor
cells. We found that assessment of cell recovery at 24 h post-
thawing, and not immediately upon thawing, was essential to
distinguish between good and poor cryopreservation conditions.
Furthermore, we challenge the notion that rapid thawing
of cells is necessarily better than slow thawing conditions.
Indeed, non-linear cooling and warming conditions could
further improve the cell viability and total cell yield of
human mDA neural progenitor cells, and this warrants further
investigation. Other parameters that can be investigated
include cell density, total freezing volume, and cryovial
type (material, wall thickness), which were all kept constant
in this study. High-quality cryopreserved mDA neural
progenitor cells with high post-thaw viability will be a valuable
resource for the neuroscience research community, and could
facilitate the efforts toward cell replacement therapy for
Parkinson’s by providing a time window for safety testing and
assessment of efficacy.
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